Advanced Materials Aerospace & defense Agriculture Automation & Process Control Automotive & Transportation Banking & Financial Services Biotechnology Building & Construction Chemicals Cloud Computing Communications Devices and Infrastructure Consumer Goods Country Reports Cyber Security Data Center & Networking Energy Energy Utilities Food & Beverage Global Reports Healthcare Industrial Goods Industry Updates Information and Communications Technology IoT, Bigdata & Digitalization IT & Telecom Medical Devices Mining, Minerals and Metals Networking and Communications Next-Generation Networking Technologies Oil & Gas Outsourcing Services Packaging Pharmaceuticals Regional Reports Semiconductor & Electronics Software & Solutions Technology & Media Travel & Tourism
-
Hepatitis C Treatment Market
The Global Hepatitis C Treatment Market is projected to grow from USD 8,698.4 million in 2024 to an estimated USD 11,737.4 million by 2032, with a compound annual growth rate (CAGR) of 3.80% from 2025 to 2032.
-
Hemophilia Treatment Market
The Global Hemophilia Treatment Market is projected to grow from USD 28,437.5 million in 2024 to an estimated USD 87,015.4 million by 2032, with a compound annual growth rate (CAGR) of 15.03% from 2025 to 2032.
-
Digestive Enzymes Supplements Market
The Global Digestive Enzymes Supplements Market is projected to grow from USD 2,078.7 million in 2024 to an estimated USD 3,236.5 million by 2032, with a compound annual growth rate (CAGR) of 5.66% from 2025 to 2032.
-
Periodontal Therapeutics Market
The Global Periodontal Therapeutics Market is projected to grow from USD 2,557.8 million in 2024 to an estimated USD 4,679.4 million by 2032, with a compound annual growth rate (CAGR) of 7.86% from 2025 to 2032.
-
Hereditary Angioedema Market
The Hereditary Angioedema market size was valued at USD 2,010.4 million in 2018, increased to USD 3,144.8 million in 2024, and is anticipated to reach USD 5,161.2 million by 2032, at a CAGR of 6.33% during the forecast period.
-
Malignant Ascites Market
The Global Malignant Ascites Market size was valued at USD 673.94 million in 2018 to USD 1,122.40 million in 2024 and is anticipated to reach USD 2,269.91 million by 2032, at a CAGR of 8.57% during the forecast period.
-
Bovine Respiratory Disease Treatment Market
The Bovine Respiratory Disease Treatment Market size was valued at USD 879.1 million in 2018 to USD 1,317.9 million in 2024 and is anticipated to reach USD 2,254.9 million by 2032, at a CAGR of 6.97% during the forecast period.
-
Aspirin Drug Market
The Aspirin Drug Market size was valued at USD 1,529.77 million in 2018, reached USD 1,907.17 million in 2024, and is anticipated to reach USD 2,506.47 million by 2032, at a CAGR of 3.23% during the forecast period.
-
Drug Discovery Enzymes Market
Drug Discovery Enzymes Market size was valued at USD 991 million in 2024 and is anticipated to reach USD 1615.6 million by 2032, at a CAGR of 6.3% during the forecast period (2024-2032).
-
Kidney Cancer/Renal Cell Carcinoma Drugs Market
The Renal Cell Carcinoma (RCC) Drugs Market size was valued at USD 3,873.8 million in 2018, increased to USD 5,776.4 million in 2024, and is anticipated to reach USD 9,313.8 million by 2032, at a CAGR of 6.13% during the forecast period.
